XELB:NASDAQXcel Brands, Inc Analysis
Data as of 2026-08-01 - not real-time
$1.20
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Xcel Brands (XELB) is trading at $1.20, just above its computed support of $1.14 and well below the 52‑week high of $2.66, indicating limited upside room. The 20‑day SMA ($1.389) sits above the current price, while the 50‑day SMA ($1.756) is markedly higher, reflecting a bearish medium‑term price bias. However, the RSI of 33 suggests the stock is oversold, and the MACD shows a marginal bullish crossover (histogram +0.0003), hinting at a possible short‑term rebound. Volatility is extreme at ~74 % over the past 30 days and beta exceeds 1.7, underscoring a highly volatile and market‑sensitive profile.
Fundamentally, the company is in distress: trailing EPS is –$4.32, operating margin is –159 %, and cash flow is deeply negative with $7.9 M free‑cash‑flow deficit. Debt totals $17.5 M against a modest cash balance of $0.18 M, yielding a debt‑to‑equity ratio over 130 %. The price‑to‑book of 0.46 suggests a discount to net assets, but the lack of earnings and a negative ROE (‑89 %) raise serious concerns. No dividend is paid, and the forward PE is negative. The recent licensing agreement with KBL Group for the OFF/DUTY brand could provide a modest revenue boost, but its impact is uncertain given the company's overall financial weakness.
Fundamentally, the company is in distress: trailing EPS is –$4.32, operating margin is –159 %, and cash flow is deeply negative with $7.9 M free‑cash‑flow deficit. Debt totals $17.5 M against a modest cash balance of $0.18 M, yielding a debt‑to‑equity ratio over 130 %. The price‑to‑book of 0.46 suggests a discount to net assets, but the lack of earnings and a negative ROE (‑89 %) raise serious concerns. No dividend is paid, and the forward PE is negative. The recent licensing agreement with KBL Group for the OFF/DUTY brand could provide a modest revenue boost, but its impact is uncertain given the company's overall financial weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Oversold RSI and marginal bullish MACD signal
- Price near technical support
- Decreasing volume and high short‑term volatility
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative earnings and operating margins
- Heavy debt load relative to cash
- Elevated beta and 30‑day volatility
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Structural cash‑flow deficits and poor ROE
- Absence of dividend and limited growth prospects
- Uncertain upside from licensing agreement amid high financial risk
Key Metrics & Analysis
Financial Health
Revenue Growth-14.10%
P/E Ratio-0.6
ROE-88.78%
ROA-10.11%
Debt/Equity133.12
P/B Ratio0.5
Op. Cash Flow$-6466000
Free Cash Flow$-7929000
Technical Analysis
TrendNeutral
RSI33.1
Support$1.14
Resistance$1.98
MA 20$1.39
MA 50$1.76
MA 200$1.57
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Target Price$5.00
Upside/Downside316.67%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.72
Volatility73.77%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.